4.3 Review

Long-term Consequences of COVID-19: Chemosensory Disorders

Related references

Note: Only part of the references are listed.
Article Otorhinolaryngology

Patterns and clinical outcomes of olfactory and gustatory disorders in six months: Prospective study of 1031 COVID-19 patients

Ahmed Abdelmoneim Teaima et al.

Summary: This study found that most cases of olfactory and gustatory dysfunction caused by COVID-19 infection recover within the first two weeks, with recovery not directly related to olfactory training, treatment received, or patient demographics. Parosmia was identified as an independent predictor for complete recovery, while phantosmia was associated with a lower probability of complete recovery.

AMERICAN JOURNAL OF OTOLARYNGOLOGY (2022)

Article Infectious Diseases

Self-reported olfactory and gustatory dysfunctions in COVID-19 patients: a 1-year follow-up study in Foggia district, Italy

Francesca Fortunato et al.

Summary: This study found that approximately one third of patients with mild COVID-19 symptoms still experienced olfactory and gustatory dysfunctions up to 12 months after the onset of the disease. Further investigations are needed to understand the implications of these long-term effects on patients' quality of life and pathophysiology.

BMC INFECTIOUS DISEASES (2022)

Article Otorhinolaryngology

Long-lasting olfactory dysfunction in COVID-19 patients

Bernhard Prem et al.

Summary: Our results demonstrate that long-lasting olfactory dysfunction after SARS-CoV-2 infection is a common symptom. The majority of patients had olfactory dysfunction in the range of hyposmia, which was confirmed by comprehensive smell tests.

EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY (2022)

Article Health Care Sciences & Services

Exploring Trajectory Curves from Loss of Smell and Taste in Previously Hospitalized COVID-19 Survivors: the LONG-COVID-EXP-CM Multicenter Study

Cesar Fernandez-de-las-Penas et al.

JOURNAL OF GENERAL INTERNAL MEDICINE (2022)

Article Clinical Neurology

Persistent chemosensory dysfunction in a young patient with mild COVID-19 with partial recovery 15 months after the onset

Maria Paola Cecchini et al.

Summary: A 17-year-old female patient experienced long-lasting anosmia after a mild infection, with partial recovery 15 months later. Neuroimaging did not show microvascular injury in olfactory bulbs and brain, and the patient exhibited symptoms of anosmia with parosmia phenomena and gustatory impairment. Immunocytochemistry of olfactory mucosa swabs revealed high expression of ACE2 in sustentacular cells and lower expression in neuronal-shaped cells. Further longitudinal studies are needed to investigate the persistence of chemosensory impairment.

NEUROLOGICAL SCIENCES (2022)

Article Medicine, General & Internal

Prevalence of olfactory dysfunction and quality of life in hospitalised patients 1 year after SARS-CoV-2 infection: a cohort study

Hui Qi Mandy Tan et al.

Summary: This study aimed to investigate the long-term prevalence of olfactory and/or gustatory dysfunction in previously hospitalised patients with COVID-19, as well as the associated risk factors and impact on quality of life. The study found that 12.8% of patients still reported problems with smell or taste up to a year after infection, which had a negative impact on their quality of life, particularly their psychological well-being.

BMJ OPEN (2022)

Letter Otorhinolaryngology

Long-term olfactory dysfunction in COVID-19 patients: 18-month follow-up study

Fabio Ferreli et al.

INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY (2022)

Article Dentistry, Oral Surgery & Medicine

Long-term prevalence of taste and olfactory dysfunction in COVID-19 patients: A cross-sectional study

Daiana Reis et al.

Summary: This study investigated the long-term prevalence of olfactory disorder and taste disorder in COVID-19 patients in southeastern Brazil. The results showed that approximately 72.9% of patients had olfactory disorder and 67.4% had taste disorder at the time of diagnosis. After an average follow-up period of 179 days, 45% and 50% of patients still had some degree of symptoms. Age was found to be positively correlated with the prevalence of olfactory disorder.

ORAL DISEASES (2022)

Article Multidisciplinary Sciences

Persisting olfactory dysfunction in post-COVID-19 is associated with gustatory impairment: Results from chemosensitive testing eight months after the acute infection

Constantin A. Hintschich et al.

Summary: Olfactory and gustatory disorders are prominent symptoms of acute COVID-19. This study assessed olfaction and gustation using psychophysical tests eight months after COVID-19. The results show that 18% of patients had hyposmia and even 32% had hypogeusia.

PLOS ONE (2022)

Review Public, Environmental & Occupational Health

Symptoms and signs of long COVID: A rapid review and meta-analysis

Quin Healey et al.

Summary: This study summarized the most common symptoms and signs associated with Long COVID through longitudinal cohort studies, including fatigue, dyspnea, olfactory dysfunction, etc. The meta-analysis showed high heterogeneity, indicating the need for cautious interpretation.

JOURNAL OF GLOBAL HEALTH (2022)

Review Infectious Diseases

Sequelae of COVID-19 among previously hospitalized patients up to 1 year after discharge: a systematic review and meta-analysis

Tianqi Yang et al.

Summary: This review and meta-analysis found that previously hospitalized COVID-19 patients can experience a wide range of sequelae, with some symptoms persisting up to 1 year. Fatigue and somnipathy were the most commonly reported sequelae, while COVID-19 patients from Asia had a lower prevalence of symptoms compared to other regions.

INFECTION (2022)

Letter Medicine, General & Internal

Olfactory Dysfunction in Patients With Mild COVID-19 During Gamma, Delta, and Omicron Waves in Rio de Janeiro, Brazil

Cynthia Chester Cardoso et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2022)

Letter Otorhinolaryngology

Two-Year Prevalence and Recovery Rate of Altered Sense of Smell or Taste in Patients With Mildly Symptomatic COVID-19

Paolo Boscolo-Rizzo et al.

Summary: This cohort study aimed to estimate the 2-year prevalence and recovery rate of smell or taste dysfunction in patients with mildly symptomatic COVID-19.

JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY (2022)

Review Otorhinolaryngology

A Systematic Review of the Neuropathologic Findings of Post-Viral Olfactory Dysfunction: Implications and Novel Insight for the COVID-19 Pandemic

Jason C. Lee et al.

Summary: This study reviewed existing primary literature related to post-viral olfactory dysfunction, highlighting the underlying pathophysiological mechanisms and future research directions, emphasizing the relevance to the current COVID-19 pandemic. It was found that viral effects on the olfactory system vary significantly based on viral substrain, generally involving damage or alteration in components of the olfactory epithelium and/or the olfactory bulb.

AMERICAN JOURNAL OF RHINOLOGY & ALLERGY (2021)

Article Otorhinolaryngology

Olfactory and Gustatory Dysfunctions as a Clinical Manifestation of Coronavirus Disease 2019 in a Malaysian Tertiary Center

Kuganathan Ramasamy et al.

Summary: This study investigated the prevalence and recovery rate of olfactory and gustatory dysfunction among patients with COVID-19 infection. It found that most patients achieved rapid and complete recovery within 7 days, and sudden onset of olfactory and gustatory dysfunction should be recognized as a major symptom of COVID-19.

ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY (2021)

Article Otorhinolaryngology

Chemosensory dysfunction in COVID-19 out-patients

Maria Jesus Rojas-Lechuga et al.

Summary: The study found that COVID-19 patients had a significantly higher frequency of smell and taste loss compared to controls, with simultaneous OGD being more frequent in the COVID-19 group. Young and female subjects were more likely to experience OGD, and those with severe symptoms took longer to recover than those with mild symptoms.

EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY (2021)

Article Infectious Diseases

Prevalence of hyposmia and hypogeusia in 390 COVID-19 hospitalized patients and outpatients: a cross-sectional study

Agathe Nouchi et al.

Summary: The study showed that hyposmia and hypogeusia are common symptoms in COVID-19 patients, especially in young, non-severe cases. These symptoms may serve as a useful diagnostic tool for initial evaluation of suspected COVID-19 patients.

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2021)

Letter Infectious Diseases

Long-term persistence of olfactory and gustatory disorders in COVID-19 patients

Nhu Ngoc Nguyen et al.

CLINICAL MICROBIOLOGY AND INFECTION (2021)

Article Biochemistry & Molecular Biology

Article Visualizing in deceased COVID-19 patients how SARS-CoV-2 attacks the respiratory and olfactory mucosae but spares the olfactory bulb

Mona Khan et al.

Summary: Anosmia, the loss of smell, is a common symptom of COVID-19, but it is caused by the virus attacking sustentacular cells in the olfactory mucosa rather than infecting olfactory sensory neurons. This suggests that SARS-CoV-2 is not a neurotropic virus.
Article Otorhinolaryngology

Efficacy and safety of oral corticosteroids and olfactory training in the management of COVID-19-related loss of smell

Serge-Daniel Le Bon et al.

Summary: This pilot study suggests that the combination of a short course of oral corticosteroids and olfactory training is safe and beneficial in helping patients with enduring dysosmia recover from olfactory loss due to COVID-19. Larger cohorts are needed to further investigate and confirm these findings.

EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY (2021)

Article Otorhinolaryngology

Corticosteroid nasal spray for recovery of smell sensation in COVID-19 patients: A randomized controlled trial

Abdelrahman Ahmed Abdelalim et al.

Summary: The study found that using mometasone furoate nasal spray as a topical corticosteroid for post COVID-19 anosmia did not offer significant benefits over olfactory training, with no statistical differences in treatment outcomes and recovery rates.

AMERICAN JOURNAL OF OTOLARYNGOLOGY (2021)

Article Behavioral Sciences

Six-Month Psychophysical Evaluation of Olfactory Dysfunction in Patients with COVID-19

Paolo Boscolo-Rizzo et al.

Summary: This study found that as the time since virus infection increases, olfactory dysfunction becomes more common among patients, with a high percentage showing persistent dysfunction despite most patients subjectively reporting normal smell.

CHEMICAL SENSES (2021)

Article Infectious Diseases

Onset, duration and unresolved symptoms, including smell and taste changes, in mild COVID-19 infection: a cohort study in Israeli patients

Hadar Klein et al.

Summary: Longitudinal study on mild COVID-19 patients over a 6-month period revealed that nearly half of the patients still had unresolved symptoms after 6 months, with common persistent symptoms including fatigue, changes in smell and taste, and breathing difficulties.

CLINICAL MICROBIOLOGY AND INFECTION (2021)

Review Allergy

Chemosensory Dysfunction in Patients with COVID-19: What Do We Learn from the Global Outbreak?

Ming Zeng et al.

Summary: Studies from around the world have shown that chemosensory dysfunction is common in patients with COVID-19, but the prevalence of smell and/or taste disorders varies significantly among different ethnic and geographic populations. While the pathogenesis of chemosensory dysfunction remains unclear, suggestions for diagnosis and treatment of COVID-19 patients with smell and taste disorders have been summarized.

CURRENT ALLERGY AND ASTHMA REPORTS (2021)

Article Cell Biology

Characterization and Biomarker Analyses of Post-COVID-19 Complications and Neurological Manifestations

Bing Sun et al.

Summary: A study showed increased levels of plasma cytokines and nEV proteins in individuals recovering from COVID-19, potentially leading to neuronal dysfunction, especially in patients with neurological issues and those recovering from the infection. Longitudinal studies are needed to monitor these biomarkers to assess neural damage and systemic effects.

CELLS (2021)

Article Medicine, Research & Experimental

Self-reported Taste and Smell Disorders in Patients with COVID-19: Distinct Features in China

Jia Song et al.

Summary: This study aimed to explore the frequencies of nasal symptoms in COVID-19 patients, finding that loss of taste was significantly associated with severity of the disease, unlike loss of smell. Interleukin-6 and lactate dehydrogenase serum levels were positively correlated with loss of taste scores, and most patients recovered from smell and taste dysfunction within 2 weeks.

CURRENT MEDICAL SCIENCE (2021)

Article Otorhinolaryngology

The outcome of fluticasone nasal spray on anosmia and triamcinolone oral paste in dysgeusia in COVID-19 patients

Chandra Veer Singh et al.

Summary: The study demonstrated that the use of fluticasone nasal spray and triamcinolone paste significantly improved olfactory and taste function in COVID-19 patients, with faster recovery compared to the control group.

AMERICAN JOURNAL OF OTOLARYNGOLOGY (2021)

Article Otorhinolaryngology

Long-term follow-up of olfactory and gustatory dysfunction in COVID-19: 6 months case-control study of health workers

Juan Riestra-Ayora et al.

Summary: In COVID-19 patients, olfactory and gustatory dysfunction showed high-resolution rates within the first two months after onset, but 11% did not fully recover and 30% partially recovered after 6 months. There was a high correlation between olfactory and gustatory dysfunction, while nasal obstruction and dyspnea were identified as risk factors for symptom persistence.

EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY (2021)

Article Otorhinolaryngology

Six-month smell and taste recovery rates in coronavirus disease 2019 patients: a prospective psychophysical study

M. Petrocelli et al.

Summary: A study found that six months after the onset of COVID-19, about 6% of patients still had severe persistent olfactory or gustatory disturbances.

JOURNAL OF LARYNGOLOGY AND OTOLOGY (2021)

Article Health Care Sciences & Services

Olfactory Training and Visual Stimulation Assisted by a Web Application for Patients With Persistent Olfactory Dysfunction After SARS-CoV-2 Infection: Observational Study

Fabrice Denis et al.

Summary: This study found that olfactory training and visual stimulation assisted by a dedicated web application significantly improved olfaction in patients, especially after at least 28 days of olfactory training.

JOURNAL OF MEDICAL INTERNET RESEARCH (2021)

Review Medicine, General & Internal

Short-term and Long-term Rates of Postacute Sequelae of SARS-CoV-2 Infection A Systematic Review

Destin Groff et al.

Summary: This systematic review found that more than half of COVID-19 survivors experienced PASC 6 months after recovery, with the most common effects being functional mobility impairments, pulmonary abnormalities, and mental health disorders.

JAMA NETWORK OPEN (2021)

Review Biochemistry & Molecular Biology

Post-acute COVID-19 syndrome

Ani Nalbandian et al.

Summary: SARS-CoV-2 is responsible for the COVID-19 pandemic, causing global healthcare crises. Recovery from COVID-19 may lead to persistent symptoms and long-term complications, prompting the need for multidisciplinary care and follow-up for survivors.

NATURE MEDICINE (2021)

Article Otorhinolaryngology

Eight-month follow-up of olfactory and gustatory dysfunctions in recovered COVID-19 patients

Ameen Biadsee et al.

Summary: The study investigated recovery of loss of smell and taste among recovered COVID-19 patients, finding that complete recovery occurred in 52% and 61.5% for olfactory and gustatory functions, respectively, with dysfunction persisting in 48%-38.5% of patients. Gender did not significantly affect recovery, but patients who initially experienced olfactory dysfunction had lower recovery rates.

AMERICAN JOURNAL OF OTOLARYNGOLOGY (2021)

Article Otorhinolaryngology

Quality of life and safety impact of COVID-19 associated smell and taste disturbances

Daniel H. Coelho et al.

Summary: The association between COVID-19 and chemosensory loss significantly impacts the quality of life and safety of patients, with almost all respondents reporting at least one deficit. Depression was self-reported by over 43% of subjects, while over half reported at least one safety-related issue.

AMERICAN JOURNAL OF OTOLARYNGOLOGY (2021)

Article Behavioral Sciences

Chemosensory Dysfunctions Induced by COVID-19 Can Persist up to 7 Months: A Study of Over 700 Healthcare Workers

Nicholas Bussiere et al.

Summary: Studies have shown that some COVID-19 patients may experience chemosensory alterations or impairments. A research on 704 healthcare workers revealed that a significant proportion of infected individuals still have chemosensory impairments 3-7 months after their infection.

CHEMICAL SENSES (2021)

Letter Geriatrics & Gerontology

Age and subtle cognitive impairment are associated with long-term olfactory dysfunction after COVID-19 infection

Viviana Cristillo et al.

JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2021)

Review Pathology

ACE2 & TMPRSS2 Expressions in Head & Neck Tissues: A Systematic Review

Jerome R. Lechien et al.

Summary: The review found that ACE2 and TMPRSS2 are widely expressed in head and neck tissues, playing an important role in viral entry into the host organism. There are differences in expression levels among different cell types and locations, with TMPRSS2 expressed in respiratory cells and ACE2 more prominent in oral and sinus nasal mucosa.

HEAD & NECK PATHOLOGY (2021)

Article Behavioral Sciences

Six-Month Psychophysical Evaluation of Olfactory Dysfunction in Patients with COVID-19

Paolo Boscolo-Rizzo et al.

Summary: This study prospectively assessed the 6-month prevalence of olfactory dysfunction in subjects with mild-to-moderate COVID-19. Despite most patients reporting a subjectively normal sense of smell, a high percentage of persistent smell dysfunction was observed at 6 months, highlighting a significant long-term rate of smell alteration in patients with previous SARS-CoV-2 infection.

CHEMICAL SENSES (2021)

Letter Medicine, General & Internal

Alterations in Smell or Taste in Mildly Symptomatic Outpatients With SARS-CoV-2 Infection

Giacomo Spinato et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

Article Biochemistry & Molecular Biology

SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes

Waradon Sungnak et al.

NATURE MEDICINE (2020)

Article Otorhinolaryngology

Evolution of Altered Sense of Smell or Taste in Patients With Mildly Symptomatic COVID-19

Paolo Boscolo-Rizzo et al.

JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY (2020)

Article Otorhinolaryngology

Olfactory and Gustatory Outcomes in COVID-19: A Prospective Evaluation in Nonhospitalized Subjects

Alberto Paderno et al.

OTOLARYNGOLOGY-HEAD AND NECK SURGERY (2020)

Review Otorhinolaryngology

Treatment of post-viral olfactory dysfunction: an evidence-based review with recommendations

Nanki Hura et al.

INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY (2020)

Article Otorhinolaryngology

Association of chemosensory dysfunction and COVID-19 in patients presenting with influenza-like symptoms

Carol H. Yan et al.

INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY (2020)

Article Medicine, General & Internal

Smell and Taste in Severe CoViD-19: Self-Reported vs. Testing

Andrea Mazzatenta et al.

FRONTIERS IN MEDICINE (2020)

Article Medicine, General & Internal

Cerebral Micro-Structural Changes in COVID-19 Patients - An MRI-based 3-month Follow-up Study

Yiping Lu et al.

ECLINICALMEDICINE (2020)

Review Otorhinolaryngology

Clinical Diagnosis and Current Management Strategies for Olfactory Dysfunction: A Review

Katherine L. Whitcroft et al.

JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY (2019)

Article Otorhinolaryngology

Prognosis of Olfactory Dysfunction according to Etiology and Timing of Treatment

Do Hyun Kim et al.

OTOLARYNGOLOGY-HEAD AND NECK SURGERY (2017)

Review Otorhinolaryngology

Efficacy of olfactory training in patients with olfactory loss: a systematic review and meta-analysis

Kelly Pekala et al.

INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY (2016)

Article Neurosciences

EFFECTS OF CHRONIC PERIPHERAL OLFACTORY LOSS ON FUNCTIONAL BRAIN NETWORKS

K. Kollndorfer et al.

NEUROSCIENCE (2015)

Article Multidisciplinary Sciences

Impaired learning resulting from Respiratory Syncytial Virus infection

Janyra A. Espinoza et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)

Article Otorhinolaryngology

Treatment of Postviral Olfactory Loss With Glucocorticoids, Ginkgo biloba, and Mometasone Nasal Spray

Beom Seok Seo et al.

ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY (2009)